ARS Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ARS Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98% to $30,000. Profit margin reached -181217%. Total operating expenses were $67,550,000.
Profit Margin
| 2019 | 0 | -23.96M | |
|---|---|---|---|
| 2020 | 17.83M | -1.06M | -5.97% |
| 2021 | 5.50M | -20.24M | -367.65% |
| 2022 | 1.31M | -33.98M | -2582.67% |
| 2023 | 30K | -54.36M | -181216.67% |
SPRY Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 30K | 1.31M | 5.50M | 17.83M | 0 |
Cost of revenue | 73K | 17.32M | 20.27M | 14.07M | 1.54M |
Gross profit | -43K | -16.00M | -14.76M | 3.76M | -1.54M |
Operating exp. | |||||
Research and development | 20.26M | 18.37M | 20.27M | 14.07M | 21.50M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 67.55M | 36.83M | 24.96M | 18.30M | 22.52M |
Operating income | -67.52M | -35.51M | -19.45M | -469K | -24.06M |
Other income (expenses), net | 13.15M | 834K | -789K | -596K | 100K |
Income before tax | -54.36M | -34.68M | -20.24M | -1.06M | -23.96M |
Income tax expense | 0 | -694K | 0 | -200.29K | 0 |
Net income | -54.36M | -33.98M | -20.24M | -1.06M | -23.96M |
Earnings per share | |||||
Basic EPS | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 |
Diluted EPS | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 |
| Data source | Data source | Data source |